Doug Williams, new Sana R&D chief (Codiak website)
April 10, 2023 04:05 PM EDT
People
Bioregnum

In a bit­ter­sweet tran­si­tion, Doug Williams takes on his next big biotech chal­lenge

Doug Williams is mov­ing on.

Just days af­ter sound­ing taps in bank­rupt­cy court over Co­di­ak Bio­Sciences, where he helped spear­head the work as CEO …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

The brain is Eli Lil­ly's next tar­get for its obe­si­ty meds

The End­points 100: The biotech in­dus­try braces for Trump 2.0

Dur­ing Covid, RFK Jr. lob­bied against vac­cine EUAs for chil­dren. As HHS sec­re­tary, he could re­scind them

Lil­ly’s oral SERD makes strides in breast can­cer with Phase 3 da­ta

Drugs are ap­proved — and made avail­able — faster in US than most of EU, da­ta show

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times